In the attempt to identify obesity-driven tumour susceptibility pathways that might alter energy balance, leptin–LEPR signalling has been a focus of cancers of which the normal stem cells express LEPR and exist in a fatty tissue microenvironment in which local leptin is high35,40,41. The gene discussed is LEPR; the disease is cancer.